Innovations in viscosupplementation offerings and the popularity of minimally invasive procedures will have a positive impact on the market, due to the shorter treatment regimen and the convenience offered by these products.The dominant position of the vendors is mainly due to their product offerings and their wide acceptability in the market. For instance, Sanofi has an established product portfolio and its key products Synvisc-One and Synvisc are used in the treatment of knee osteoarthritis. The product is widely accepted as a singleinjection cycle viscosupplement.

PART 01: Executive summary ............................................ 6

Highlights 6

PART 02: Scope of the report ............................................. 7

Market overview 7

Vendor analysis 8

Top-vendor offerings 9

PART 03: Market research methodology ......................... 11

Research methodology 11

Economic indicators 11

PART 04: Introduction ....................................................... 12

Key market highlights 12

PART 05: Market landscape .............................................. 17

Market overview 17

Market size and forecast 18

Five forces analysis 21

PART 06: Market segmentation by products ................... 22

Market overview 22

Single-injection cycle market 25

Three-injection cycle market 27

Five-injection cycle market 29

PART 07: Geographical segmentation ............................. 31

Market overview 31

Viscosupplementation market in Americas 33

Viscosupplementation market in EMEA 35

Viscosupplementation market in APAC 37

PART 08: Market drivers ................................................... 40

PART 09: Impact of drivers ............................................... 43

PART 10: Market challenges ............................................. 44

PART 11: Impact of drivers and challenges .................... 47

PART 12: Market trends .................................................... 48

PART 13: Vendor landscape ............................................. 50

Competitive scenario 50

Market vendor ranking analysis 2015 52

PART 14: Key vendor analysis ......................................... 53

Geographic presence: Key vendor analysis 53

Sanofi 54

Anika Therapeutics 58

Seikagaku 63

Fidia Farmaceutici 67

Ferring Pharmaceuticals 71

Other prominent vendors 74

PART 15: Appendix............................................................ 78

List of abbreviations 78

PART 16: Explore Technavio ............................................ 79